Back to results
US 2026/0226087 A1Published application
Crystalline forms of tenofovir alafenamide
AssigneeGilead Sciences, Inc.
InventorsChiajen Lai, Bing Shi, Robert G. Strickley
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel crystalline forms of salts and/or co-crystals of tenofovir alafenamide, the pharmaceutical formulations, and the therapeutic uses thereof in treating viral infections.
Claims20
Crystalline Tenofovir Alafenamide Bis-Xinafoate, characterized by an X-ray powder diffraction pattern having peaks at about 4.5°, 8.9°, 11.2°, 14.4°, 15.4°, 18.8°, 21.7°, and 25.5° 2-θ+0.2° 2-θ.
Dependencies are inferred from the claim text.